Venture Backed Life Sciences Up Rounds Top Down Rounds In 2012
Valuations are strong for venture-backed enterprise companies and Internet startups with top prospects. What about health care? Turns out 2012 was a relatively solid year there, too. Up rounds outpaced down rounds 52% to 17% over the 12 months.
16 April 2013•1 min read
